HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6

Benzinga Newsdesk www.benzinga.com Negative 55.3%

Neg 55.3% Neu 0% Pos 0%

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $7 to $6.